Goal Vest Advisory LLC Regeneron Pharmaceuticals, Inc. Transaction History

Goal Vest Advisory LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	SELL	$775.18 - $881.7 $10,852 - $12,343	-14 Closed	0 $0
Q2 2022 Jul 06, 2022	SELL	$548.35 - $738.84 $111,863 - $150,723	-204 Reduced 93.58%	14 $8,000
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $230,906 - $270,990	-388 Reduced 64.03%	218 $152,000
Q2 2021 Sep 01, 2021	SELL	$472.8 - $558.54 $134,275 - $158,625	-284 Reduced 31.91%	606 $338,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $4,914 - $6,030	11 Added 1.25%	890 $421,000
Q4 2020 Jan 28, 2021	BUY	$478.3 - $607.98 $420,425 - $534,414	879 New	879 $425,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Goal Vest Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Goal Vest Advisory LLC with notifications on news.